FZD9 and acute myeloid leukemia: Interestingly, canonical pathway analysis of the 20 aberrantly methylated genes in AML Group II showed significant involvement of the Wnt/βcatenin signaling pathway through the aberrant methylation of FRZB, FZD9, and SOX17 (p = 0.001, Fisher exact test & ratio 3/165).